NCT00781534CompletedEarly Phase 1
A Clinical Trial of Ginseng for Glucose Intolerance
Washington University School of Medicine1 site in 1 country19 target enrollmentStarted: September 2003Last updated:
Conditions
Interventions
Drugs
Trial Snapshot
- Phase
- Early Phase 1
- Status
- Completed
- Enrollment
- 19
- Locations
- 1
Study Overview
Brief Summary
a clinical study of Ginseng its potential affect on diabetes
Detailed Description
Comparing three groups (those with & without normal blood sugar levels) to see if there is any clinically significant change in blood sugar levels in relationship to those taking:
- ginseng
- ginsenoside RE (a type of metabolized ginseng)
- placebo
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Basic Science
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to 65 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •ages 18-65
- •healthy, non-diabetic
- •healthy, impaired glucose tolerance/mild diabetes (no medications required)
Exclusion Criteria
- •impaired glucose tolerance (borderline diabetes that requires medications)
- •diabetes (requiring medications)
- •caffeine sensitivity
- •known cardiac, peripheral vascular diseases
- •arrhythmias (irregular heart rhythms)
Arms & Interventions
1. Ginseng
Active Comparator
Ginseng group
Intervention: Ginseng (Drug)
2. Ginsenosdie RE
Active Comparator
Ginsenoside RE (a metabolite of ginseng) group
Intervention: Ginseng (Drug)
2. Ginsenosdie RE
Active Comparator
Ginsenoside RE (a metabolite of ginseng) group
Intervention: ginsenoside RE (Drug)
3. Placebo
Placebo Comparator
placebo ("sugar" pill) group
Intervention: Placebo (sugar pill) (Dietary Supplement)
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Unknown
Not Applicable
Effect of Ginseng on Glycemic ControlImpaired Glucose ToleranceDiabetesNCT01841229Unity Health Toronto770
Completed
Phase 1
A Method to Evaluate Glucose-Dependent Insulin Secretion in Healthy Males (MK-0431-179)Type 2 Diabetes MellitusNCT00888238Merck Sharp & Dohme LLC12
Unknown
Not Applicable
Ginsenoside Improve Metabolic SyndromeMetabolic SyndromeNCT02034136CHA University60
Completed
Phase 1
Ginkgo Biloba Extract and the Insulin Resistance SyndromeType 2 Diabetes MellitusNCT00032474National Center for Complementary and Integrative Health (NCCIH)150
Completed
Phase 2
Hypoglycemic Effects of Fermented Red Ginseng in Subject With Impaired Fasting Glucose or Type 2 DiabetesImpaired Glucose or Type 2 DiabetesNCT01826409Chonbuk National University Hospital42